tiprankstipranks
Restart Life Sciences (NMLSF)
OTHER OTC:NMLSF
US Market

Restart Life Sciences (NMLSF) Financial Statements

Compare
22 Followers

Restart Life Sciences Financial Overview

Restart Life Sciences's market cap is currently $1.97M. The company's EPS TTM is $0; its P/E ratio is 105.00; Restart Life Sciences is scheduled to report earnings on April 24, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue
Gross Profit---$ 1.73K$ 1.63K
Operating Income$ -1.26M$ -1.94M$ -2.93M$ -1.80M$ -1.22M
EBITDA$ -1.22M$ -2.46M$ -2.68M$ -1.79M$ -1.39M
Net Income$ -1.22M$ -2.47M$ -2.68M$ -25.23M$ -1.40M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 31.06K$ 296.79K$ 881.16K$ 3.05M$ 6.58M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -8.09K$ -266.52K$ -218.73K$ -2.14M$ -847.42K
Total Liabilities$ 841.66K$ 255.44K$ 422.06K$ 382.96K$ 325.07K
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow
Operating Cash Flow$ -277.53K$ -2.41M$ -1.95M$ -856.53K$ -878.81K
Investing Cash Flow
Financing Cash Flow
Currency in USD

Restart Life Sciences Earnings and Revenue History

Restart Life Sciences Debt to Assets

Restart Life Sciences Cash Flow

Restart Life Sciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis